Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

Silvia Mateo-Lozano, Sarah Bazzocco, Paulo Rodrigues, Rocco Mazzolini, Elena Andretta, Higinio Dopeso, Yolanda Fernández, Edgar Del Llano, Josipa Bilic, Luciá Suárez-López, Irati MacAya, Fernando Cartón-Garciá, Rocio Nieto, Lizbeth M. Jimenez-Flores, Priscila Guimarães De Marcondes, Yaiza Nuñez, Elsa Afonso, Karina Cacci, Javier Hernández-Losa, Stefania LandolfiIbane Abasolo, Santiago Ramón, John M. Mariadason, Simo Schwartz, Toshimitsu Matsui, Diego Arango

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

© 2017 The Author(s). Although deregulation of EPHB signaling has been shown to be an important step in colorectal tumorigenesis, the role of EPHB6 in this process has not been investigated. We found here that manipulation of EPHB6 levels in colon cancer cell lines has no effect on their motility and growth on a solid substrate, soft agar or in a xenograft mouse model. We then used an EphB6 knockout mouse model to show that EphB6 inactivation does not efficiently initiate tumorigenesis in the intestinal tract. In addition, when intestinal tumors are initiated genetically or pharmacologically in EphB6+/+ and EphB6-/- mice, no differences were observed in animal survival, tumor multiplicity, size or histology, and proliferation of intestinal epithelial cells or tumor cells. However, reintroduction of EPHB6 into colon cancer cells significantly reduced the number of lung metastasis after tail-vein injection in immunodeficient mice, while EPHB6 knockdown in EPHB6-expressing cells increased their metastatic spread. Consistently, although EPHB6 protein expression in a series of 130 primary colorectal tumors was not associated with patient survival, EPHB6 expression was significantly lower in lymph node metastases compared to primary tumors. Our results indicate that the loss of EPHB6 contributes to the metastatic process of colorectal cancer.
Original languageEnglish
Article number43702
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 6 Mar 2017

Fingerprint Dive into the research topics of 'Loss of the EPH receptor B6 contributes to colorectal cancer metastasis'. Together they form a unique fingerprint.

Cite this